The effect of patient’s age on oncologic and survival results in patients undergoing radical cystectomy due to muscle invasive bladder cancer

Abstract

Purpose: To investigate the effect of age on oncologic and survival results in patients undergoing radical cystectomy due to muscle invasive bladder cancer. 

Material and Method: We reviewed the data of 178 patients who underwent radical cystectomy between January 2006 and November 2016 due to bladder cancer in our clinic. Finally 147 patients who underwent radical cystectomy due to muscle-invasive bladder cancer were included in the study. Patients were divided into two groups as; patient age ≤ 70 years (Group 1) and > 70 years (Group 2). Then we compared the groups in terms of preoperative data, oncological outcomes and survival findings. 

Results: There were 101 and 46 patients in group 1 and group 2 respectively. There was no statistically significant difference between the two groups in terms of gender, preoperative T stage, tumor grade, preoperative hydronephrosis and precence of carcinoma in situ (CIS). Preoperative ASA score was higher in the elderly group (Group 2) (p = 0.007). Postoperative data showed that the presence of variant histology, T stage, upstaging, tumor grade, lymph node metastasis, positive surgical margins were similar between the two groups. There was no statistically significant difference between the two groups in terms of overall survival and cancer-specific survival. 

Conclusion : There was no statistically significant difference between oncologic and survival findings between ≤ 70 years and > 70 years old patients who underwent radical cystectomy due to muscle invasive bladder cancer. 

Keywords

• bladder cancer,age,radical cystectomy

Kas invaziv mesane kanseri nedeniyle radikal sistektomi yapılan hastalarda hasta yaşının onkolojik ve sağkalım sonuçları üzerine etkisi

Abstract

Amaç : Kas invaziv mesane kanseri nedeniyle radikal sistektomi yapılan hastalarda hasta yaşının onkolojik ve sağkalım verileri üzerine etkisini araştırmak 

Gereç ve Yöntemler : Kliniğimizde mesane kanseri nedeniyle Ocak 2006-Kasım 2016 tarihleri arasında radikal sistektomi operasyonu yapılan 178 hastaya ait veriler incelendi. Çalışmaya kas invaziv mesane kanseri nedeniyle radikal sistektomi yapılan 147 hasta dahil edildi. Hastalar ≤ 70 yaş(Grup 1) ve >70 yaş (Grup 2) olmak üzere iki gruba ayrıldı. Bu iki grup preoperatif veriler, onkolojik sonuçlar ve sağkalım verileri açısından karşılaştırıldı. 

Bulgular : Grup 1 de 101 hasta, grup 2 de ise 46 hasta vardı. İki grup arasında cinsiyet, preoperatif T evresi, tümör grade i, preoperatif hidronefroz ve karsinoma in situ (CIS) varlığı açısından istatistiksel anlamlı fark yoktu. Preoperatif ASA skoru yaşlı grupta(Grup 2) daha yüksekti(p=0.007). Postoperatif verilerde varyant histoloji varlığı, T evresi, upstaging, tümör grade i, lenf nodu metastazı ve pozitif cerrahi sınır varlığı iki grup arasında benzer olarak bulundu. İki grup arasında genel sağkalım ve kanser spesifik sağkalım açısından istatistiksel anlamlı fark izlenmedi. 

Sonuç: Kas invaziv mesane tümörü nedeniyle radikal sistektomi yapılan ≤ 70 yaş ve >70 yaş hasta grupları arasında onkolojik ve sağkalım verileri açısından istatistiksel anlamlı fark izlenmedi. 

Keywords

• mesane kanseri;,yaş,radikal sistektomi

References

1. 1. Howlader N, Noone AM, Krapcho M, et al. Seer cancer statistics review, 1975–2011. 2014. http://seer.cancer.gov/csr/1975_2011/ Accessed 15January 2015.
2. 2. Taylor JA 3rd, Kuchel GA. Bladder cancer in the elderly:clinical outcomes, basic mechanisms, and future research direction.Nat Clin Pract Urol 2009;6:135–44.
3. 3. Metts MC, Metts JC, Milito SJ, et al. Bladder cancer: a review of diagnosis and management. J Natl Med Assoc 2000;92:285–294.
4. 4. Berger I, Martini T, Wehrberger C, et al. Perioperative complications and 90-day mortality of radical cystectomy in the elderly (75ş): A retrospective, multicentre study. Urol Int 2014;93:296–302.
5. 5. Donat SM, Siegrist T, Cronin A, et al.: Radical cystectomy in octogenarians—does morbidity outweigh the potential survival benefits. J Urol 2010;183:2171–2177
6. 6. Horovitz D, Turker P, Bostrom PJ, et al. Does patient age affect survival after radical cystectomy. BJU Int 2012;110:E486–E493.
7. 7. Tyritzis SI, Anastasiou I, Stravodimos KG, et al. Radical cystectomy over the age of 75 is safe and increases survival. BMC Geriatr 2012;12:18.
8. 8. Clark PE, Stein JP, Groshen SG, et al. Radical cystectomy in the elderly: Comparison of clincal outcomes between younger and older patients. Cancer 2005;104:36–43.

9. 9. Rostoft S. Introduction. Ed. Aapro S, Schrijvers D. ESMO handbook of cancer in the senior patient 2.nd Edition 2015:1-7
10. 10. Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer:epidemiology, staging and grading, and diagnosis. Urology 2005;66:4-34. 11. Fleshner N, Kondylis E. Demographics and epidemiology of urothelial cancer of the urinary bladder. In Droller MI(ed): Urothelial Tumors. Hamilton, Ontario: Decker 2004.p.1-16.
11. 12. Raghavan D. Management of advanced bladder cancer in the elderly. Urol Clin North Am 1992;19:797-806.
12. 13. Hollenbeck BK, MillerDC, Taub D, et al. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 2004;64:292–7.
13. 14. Prout GR Jr., Wesley MN, Yancik R, et al. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study.Cancer 2005;104: 1638–47.
14. 15. Fonteyne V, Ost P, Bellmunt J, et al. Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review. Eur Urol 2018;73:40-50.
15. 16. Bostrom PJ, Kossi J, Laato M et al. Risk factors formortality and morbidity related to radical cystectomy. BJU Int 2009;103:191-6.
16. 17. Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009;55:164-76.
17. 18. Figueroa AJ, Stein JP, Dickinson M, et al. Radical cystectomy for elderly patients with bladder carcinoma: An updated experience with 404 patients. Cancer 1998;83:141-7.